Moderna to build mRNA vaccine plant in Africa


Moderna will spend up to $500 million to construct a vaccine manufacturing facility in Africa that can produce up to 500 million mRNA vaccine doses each year, including its COVID-19 vaccine. The possible choices for the plant's site include Rwanda, Senegal and South Africa.

Full story:

AIChE SmartBrief

Chemical engineering news

Designed specifically for chemical engineers, AIChE SmartBrief is a FREE weekly e-mail newsletter. It helps chemical engineers stay informed on the business and technology developments affecting our profession.